|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 389.50 DKK | +3.17% |
|
+1.62% | +19.75% |
| 01:04pm | NOVO NORDISK : Gets a Sell rating from Jefferies | ZD |
| 12:18pm | Novo Nordisk Targets Curative Diabetes Therapies Through Expanded Aspect Biosystems Partnership | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NOVO NORDISK A/S | Other Pharmaceuticals | +3.17% | +1.62% | +19.75% | -29.35% | +75.65% | 27TCr |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- NOVO B Stock
- Charts Novo Nordisk A/S
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition